Freenome

Freenome is a pioneering multiomics liquid biopsy company developing blood-based tests for early cancer detection, aiming for FDA approvals with leading sensitivity and specificity across major cancer types.

Company Facts

  • Headquarters: South San Francisco, United States
  • Founded: 2014
  • Type: startup
  • Website: https://www.freenome.com
  • Industries: Healthcare, Diagnostics, Oncology, Liquid Biopsy, Genomics

Investors & Owners

  • Averin Capital

Recent Transactions

  • Averin Capital investment in Freenome